S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$97.16
+0.6%
$97.56
$77.30
$114.97
$1.58B0.96113,694 shs116,377 shs
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$9.36
-0.7%
$9.78
$6.37
$15.37
$1.24B1.021.10 million shs924,477 shs
Amedisys, Inc. stock logo
AMED
Amedisys
$90.78
-0.2%
$92.84
$73.10
$96.44
$2.97B0.86283,537 shs223,250 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$10.11
-0.5%
$10.17
$7.12
$14.59
$507.12M1.96585,926 shs290,125 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
+0.56%-2.14%-3.36%+6.55%-11.16%
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-0.74%-6.87%-10.86%+36.24%-21.34%
Amedisys, Inc. stock logo
AMED
Amedisys
-0.20%-1.61%-2.18%-4.21%+18.50%
Enhabit, Inc. stock logo
EHAB
Enhabit
-0.49%-5.95%-9.57%-0.98%-19.89%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
4.3074 of 5 stars
1.45.00.05.03.02.52.5
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.6784 of 5 stars
3.12.00.00.01.83.33.8
Amedisys, Inc. stock logo
AMED
Amedisys
3.0784 of 5 stars
1.13.00.05.03.21.71.3
Enhabit, Inc. stock logo
EHAB
Enhabit
1.6366 of 5 stars
1.93.00.00.03.30.02.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
2.86
Moderate Buy$103.836.87% Upside
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
2.29
Hold$12.1029.27% Upside
Amedisys, Inc. stock logo
AMED
Amedisys
2.13
Hold$97.507.40% Upside
Enhabit, Inc. stock logo
EHAB
Enhabit
1.86
Reduce$12.0819.52% Upside

Current Analyst Ratings

Latest AHCO, ADUS, AMED, and EHAB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/26/2024
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$118.00
3/26/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
3/25/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$97.00 ➝ $100.00
3/7/2024
Enhabit, Inc. stock logo
EHAB
Enhabit
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
3/7/2024
Enhabit, Inc. stock logo
EHAB
Enhabit
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$9.50
3/6/2024
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$88.00
3/6/2024
Enhabit, Inc. stock logo
EHAB
Enhabit
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $14.00
3/4/2024
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$13.00
2/29/2024
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$102.00
2/28/2024
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$9.00 ➝ $13.00
2/28/2024
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$1.06B1.49$5.06 per share19.22$43.58 per share2.23
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.20B0.39$10.17 per share0.92$11.06 per share0.85
Amedisys, Inc. stock logo
AMED
Amedisys
$2.24B1.33$6.08 per share14.93$34.31 per share2.65
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.05B0.48$2.56 per share3.95$13.90 per share0.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$62.52M$3.8425.3020.031.915.91%9.70%6.70%5/6/2024 (Estimated)
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-$678.90M-$5.31N/A8.360.63-21.21%8.84%3.39%5/14/2024 (Estimated)
Amedisys, Inc. stock logo
AMED
Amedisys
-$9.75M-$0.31N/A18.274.29-0.44%12.76%7.02%5/1/2024 (Estimated)
Enhabit, Inc. stock logo
EHAB
Enhabit
-$80.50M-$1.62N/A33.701.57-7.69%1.55%0.76%5/8/2024 (Confirmed)

Latest AHCO, ADUS, AMED, and EHAB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.05N/A-$0.05N/AN/AN/A  
3/6/202412/31/2023
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.02$0.03+$0.01$0.25$260.30 million$260.60 million    
2/27/2024Q4 2023
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$0.20$0.64+$0.44$3.19$825.94 million$858.23 million
2/26/2024Q4 2023
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$1.04$1.21+$0.17$1.22$274.02 million$276.35 million
2/21/2024Q4 2023
Amedisys, Inc. stock logo
AMED
Amedisys
$1.04$0.94-$0.10$1.29$566.85 million$570.79 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
0.18
1.38
1.38
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.44
1.21
1.00
Amedisys, Inc. stock logo
AMED
Amedisys
0.32
1.05
1.05
Enhabit, Inc. stock logo
EHAB
Enhabit
0.76
1.53
1.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
95.35%
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A

Insider Ownership

CompanyInsider Ownership
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
4.40%
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
13.60%
Amedisys, Inc. stock logo
AMED
Amedisys
1.80%
Enhabit, Inc. stock logo
EHAB
Enhabit
1.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
34,84616.23 million15.51 millionOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,700132.91 million114.83 millionOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
19,00032.67 million32.08 millionOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,80050.16 million49.20 millionOptionable

AHCO, ADUS, AMED, and EHAB Headlines

SourceHeadline
Enhabit, Inc. (NYSE:EHAB) Receives Consensus Recommendation of "Reduce" from AnalystsEnhabit, Inc. (NYSE:EHAB) Receives Consensus Recommendation of "Reduce" from Analysts
americanbankingnews.com - April 18 at 2:32 AM
DekaBank Deutsche Girozentrale Buys 242,924 Shares of Enhabit, Inc. (NYSE:EHAB)DekaBank Deutsche Girozentrale Buys 242,924 Shares of Enhabit, Inc. (NYSE:EHAB)
marketbeat.com - April 14 at 5:10 AM
Pleasing Signs As A Number Of Insiders Buy Enhabit StockPleasing Signs As A Number Of Insiders Buy Enhabit Stock
finance.yahoo.com - April 13 at 12:37 PM
Enhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings CallEnhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings Call
businesswire.com - April 10 at 4:10 PM
Enhabit (NYSE:EHAB) Trading Down 7%Enhabit (NYSE:EHAB) Trading Down 7%
marketbeat.com - April 2 at 5:45 PM
Enhabit, Inc. (NYSE:EHAB) Short Interest UpdateEnhabit, Inc. (NYSE:EHAB) Short Interest Update
marketbeat.com - March 30 at 10:06 PM
Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA AwardEnhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award
businesswire.com - March 20 at 6:01 PM
Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA AwardEnhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award
businesswire.com - March 20 at 5:45 PM
Enhabit, Inc. (NYSE:EHAB) Sees Significant Growth in Short InterestEnhabit, Inc. (NYSE:EHAB) Sees Significant Growth in Short Interest
marketbeat.com - March 19 at 11:44 PM
‘The Idea of You’ Review: Anne Hathaway Anchors Michael Showalter’s Fluctuating Story Of Unconventional Romance – SXSW‘The Idea of You’ Review: Anne Hathaway Anchors Michael Showalter’s Fluctuating Story Of Unconventional Romance – SXSW
msn.com - March 17 at 10:17 AM
Enhabit Full Year 2023 Earnings: EPS Misses ExpectationsEnhabit Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - March 17 at 10:17 AM
Enhabit, Inc.: A Sell Rating Amid Overly Optimistic Growth Expectations and Financial ChallengesEnhabit, Inc.: A Sell Rating Amid Overly Optimistic Growth Expectations and Financial Challenges
markets.businessinsider.com - March 13 at 9:40 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Enhabit, Inc (EHAB)Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Enhabit, Inc (EHAB)
markets.businessinsider.com - March 11 at 3:08 PM
Breaking Down Enhabit: 3 Analysts Share Their ViewsBreaking Down Enhabit: 3 Analysts Share Their Views
markets.businessinsider.com - March 11 at 3:08 PM
Enhabit, Inc. (NYSE:EHAB) Q4 2023 Earnings Call TranscriptEnhabit, Inc. (NYSE:EHAB) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 10 at 1:27 PM
Enhabit, Inc. (EHAB) Q4 2023 Earnings Call TranscriptEnhabit, Inc. (EHAB) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 2:32 PM
Enhabit, Inc. (NYSE:EHAB) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?Enhabit, Inc. (NYSE:EHAB) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
finance.yahoo.com - March 9 at 9:32 AM
Enhabit Inc (EHAB) Reports Q4 Earnings: Net Loss Narrows, Adjusted EBITDA DeclinesEnhabit Inc (EHAB) Reports Q4 Earnings: Net Loss Narrows, Adjusted EBITDA Declines
finance.yahoo.com - March 7 at 5:49 PM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enhabit, Inc (EHAB) and UnitedHealth (UNH)Analysts Have Conflicting Sentiments on These Healthcare Companies: Enhabit, Inc (EHAB) and UnitedHealth (UNH)
markets.businessinsider.com - March 7 at 12:45 PM
EHAB Stock Earnings: Enhabit Beats EPS, Beats Revenue for Q4 2023EHAB Stock Earnings: Enhabit Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 6 at 11:01 PM
Recap: Enhabit Q4 EarningsRecap: Enhabit Q4 Earnings
benzinga.com - March 6 at 4:43 PM
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 GuidanceEnhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance
businesswire.com - March 6 at 4:15 PM
Projecting The Most Impactful Home-Based Care M&A In Near-Term FutureProjecting The Most Impactful Home-Based Care M&A In Near-Term Future
homehealthcarenews.com - February 15 at 6:13 PM
Jana Partners takes new stake in Trimble, buys more SPY, trims FISJana Partners takes new stake in Trimble, buys more SPY, trims FIS
msn.com - February 14 at 3:36 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Addus HomeCare logo

Addus HomeCare

NASDAQ:ADUS
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
AdaptHealth logo

AdaptHealth

NASDAQ:AHCO
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Amedisys logo

Amedisys

NASDAQ:AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Enhabit logo

Enhabit

NYSE:EHAB
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.